Patents by Inventor Kevin LAROCQUE

Kevin LAROCQUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR TARGETING TUBULIN, CH-TOG, AURORA A KINASE, TPX2, CDK5RAP2 AND/OR ASPM
    Publication number: 20200276181
    Abstract: The present disclosure relates to compounds, methods and uses thereof for targeting tubulin, ch-TOG, Aurora A kinase, TPX2, Cdk5rap2 and/or ASPM and for the treatment of cancer in a subject. For example, the compounds can comprise compounds of Formula I or a pharmaceutically acceptable salt, solvate or prodrug thereof. A, Z, RA, RB, R1, R2, R3, R4 and R5 can have different values.
    Type: Application
    Filed: November 15, 2018
    Publication date: September 3, 2020
    Applicant: VALORBEC, SEC
    Inventors: Pasquale FORGIONE, Alisa Julienne PIEKNY, Kevin LAROCQUE, Dilan Boodhai JAUNKY, Fei CHEN, Jiang Tian LIU